I’ve been banging on a bit on twitter recently about not being in favour of the Great Direct Platform Price War. However, thinking more about it, I’ve come to the conclusion that the actual price war is fine. It’s the […]
I’ve been banging on a bit on twitter recently about not being in favour of the Great Direct Platform Price War. However, thinking more about it, I’ve come to the conclusion that the actual price war is fine. It’s the […]
Nothing stands still for long in the platform market, and if you’ve read our ramblings here and in the national meejah then you’ll remember that we said we thought there would be some changes from the published charge sheet. We’ve […]
Nothing stands still for long in the platform market, and if you’ve read our ramblings here and in the national meejah then you’ll remember that we said we thought there would be some changes from the published charge sheet. We’ve […]
So here we go with the first of the week’s pricing launches in the direct platform space. AXA Self Investor (disclosure: ASI is a client of the lang cat) has been around for a wee while, but hasn’t really pushed […]
So here we go with the first of the week’s pricing launches in the direct platform space. AXA Self Investor (disclosure: ASI is a client of the lang cat) has been around for a wee while, but hasn’t really pushed […]
That’s been quite a day. Reaction to HL’s announcement has been pretty mixed – more than I thought it would have been. Hater of the day prize goes to Dan Hyde in the super soaraway Torygraph with this piece – […]
Part of being independent is having the freedom to say what you think, even when it’s not popular or doesn’t do you very much good. This normally translates to having a pop at stuck-in-the-past lifecos if you’re me, as the […]
Well, this is just tremendously inconvenient. After putting out a blog on Zurich last week and a big update to subscribers to the lang cat Guide to Platform Pricing, AXA’s only gone and made a pricing change to its Elevate […]
So Citywire report today that between them AXA, Standard Life and Old Mutual (the parent of Skandia) have spent £225m injecting capital into loss-making platforms. Standard lead the pack with a £116m injection to cover a £130m loss (2007-2009), AXA […]
